Please login to the form below

Not currently logged in
Email:
Password:

Drew Creative – name change

Drew Creative Advertising is changing its name to The Drew Agency

Celebrating its first year as healthcare's only virtual, full-service advertising agency, Drew Creative Advertising is changing its name to The Drew Agency.

"We feel the new name better reflects the diverse range of creativity now on offer through our virtual network", says Andrew Short, founder and Creative Director. "Over the past 12 months, our network of specialist teams has grown, especially in the area of digital channels."

The Drew Agency is one of few healthcare agencies that has a dedicated digital creative department, staffed by developers who specialise in brand development and promotion through Facebook, Twitter and YouTube.

Frankie Laws is also joining as client services director, and brings a wealth of experience in healthcare, gained from 17 years in the industry including a long spell in the Ogilvy group.

Frankie Laws and Andrew Scott, The Drew Agency

Frankie Laws and Andrew Short

Laws said: "Digital channels bring so many new opportunities to our clients and it's an exciting time in healthcare communications. The Drew Agency is taking a new approach to the way we deliver both digital and traditional campaigns and I'm delighted to be involved."

8th October 2009

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics